Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells

Infection and Immunity

Volumn 67, Issue 3, 1999, Pages 1050-1055

  Van Den Berg, Bernard M ^a   Beekhuizen, Henry ^a   Mooi, Frits R ^b   Van Furth, Ralph ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; HEMAGGLUTININ; OUTER MEMBRANE PROTEIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; VIRULENCE FACTOR;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIUM ADHERENCE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; BRONCHUS MUCOSA; CONTROLLED STUDY; CROSS REACTION; EPITHELIUM CELL; FIMBRIA; HUMAN; HUMAN CELL; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032975713     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.3.1050-1055.1999     Document Type: Article

References (43)

1. Arico, B., R. Gross, J. Smida, and R. Rappuoli. 1987. Evolutionary relationships in the genus Bordetella. Mol. Microbiol. 1:301-308.
2. Armstrong, S. K., and C. D. Parker. 1986. Heat-modifiable envelope proteins of Bordetella pertussis. Infect. Immun. 54:109-117.
3. Armstrong, S. K., and C. D. Parker. 1986. Surface proteins of Bordetella pertussis: comparison of virulent strains and effects of phenotypic modulation. Infect. Immun. 54:308-314.
4. Ashworth, L. A. E., A. Robinson, L. I. Irons, C. P. Morgan, and D. Isaacs. 1983. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children. Lancet ii:878-881.
5. Banks-Schlegel, S. P., A. F. Gazdar, and C. C. Harris. 1985. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines. Cancer Res. 45:1187-1197.
6. Blumberg, D. A., E. Pineda, J. D. Cherry, A. Caruso, and J. V. Scott. 1992. The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis-strain dependent. Am. J. Dis. Child. 146:1148-1150.
7. Borska, K., and M. Simkovicova. 1972. Studies on the circulation of Bordetella pertussis and Bordetella parapertussis in populations of children. J. Hyg. Epidemiol. Microbiol. Immunol. 16:159-172.
8. Brodeur, B. R., D. Martin, J. Hamel, R. D. Shahin, and C. Laferrière. 1993. Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis. Springer Semin. Immunopathol. 15:205-215. (Review.)
9. Capiau, C., S. A. Carr, M. E. Hemling, D. Plainchamp, K. Conrath, P. Hausser, E. Simoen, M. Comberbach, P. Roelants, P. Desmons, P. Permanne, and J. O. Pétre. 1990. Purification, characterization, and immunological evaluation of the 69-kDa outer membrane protein of Bordetella pertussis, p. 75-86. In C. R. Manclark (ed.), Proceedings of the Sixth International Symposium on Pertussis. DHHS publication no. (FDA) 90-1164. Department of Health and Human Services, Bethesda. Md.
10. Donchev, D., and M. Stoyanova. 1961. The epidemiological significance of the differentiation of pertussis and parapertussis. J. Hyg. Epidemiol. Microbiol. Immunol. 5:294-297.
11. Frank, D. W., and C. D. Parker. 1984. Isolation and characterization of monoclonal antibodies to Bordetella pertussis. J. Biol. Stand. 12:353-365.
12. Geuijen, C. A. W., R. J. L. Willems, M. Bongaerts, J. Top, H. Gielen, and F. R. Mooi. 1997. Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect. Immun. 65: 4222-4228.
13. Hazenbos, W. L. W., B. M. van den Berg, J. W. van't Wout, F. R. Mooi, and R. van Furth. 1994. Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect. Immun. 62:4818-4824.
14. He, Q., M. K. Viljanen, R. Olander, H. Bogaerts, D. De Grave, O. Ruuskanen, and J. Mertsola. 1994. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. J. Infect. Dis. 170:705-708.
15. Heininger, U., K. Stehr, S. Schmitt-Grohe, C. Lorenz, R. Rost, P. D. Christenson, M. Uberall, and J. D. Cherry. 1994. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J. 13:306-309.
16. Jones, D. H., B. W. McBride, H. Jeffery, D. T. O'Hagan, A. Robinson, and G. H. Farrar. 1995. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine 13:675-681.
17. Jones, D. H., B. W. McBride, C. Thornton, D. T. O'Hagan, A. Robinson, and G. H. Farrar. 1996. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. Infect. Immun. 64:489-494.
18. Khelef, N., B. Danve, M.-J. Quentin-Millet, and N. Guiso. 1993. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect. Immun. 61:486-490.
19. Lautrop, H. 1971. Epidemics of parapertussis: 20 years' observations in Denmark. Lancet i:1195-1199.
20. Le Blay, K., M. Caroff, F. Blanchard, M. B. Perry, and R. Chaby. 1996. Epitopes of Bordetella pertussis lipopolysaccharides as potential markers for typing of isolates with monoclonal antibodies. Microbiology 142:971-978.
21. Linnenman, C. C., Jr., and E. B. Perry. 1977. Bordetella parapertussis: recent experience and a review of the literature. Am. J. Dis. Child. 131:560-563.
22. Mertsola, J. 1985. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland. Eur. J. Clin. Microbiol. 4:123-128.
23. Mills, K. H. G., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
24. Mink, C. M., C. H. O'Brien, S. Wassilak, A. Deforest, and B. D. Meade. 1994. Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect. Immun. 62:1118-1120.
25. Mooi, F. R., H. G. J. van der Heide, A. R. ter Avest, K. G. Welinder, I. Livey, B. A. M. van der Zeijst, and W. Gaastra. 1987. Characterization of fimbrial subunits from Bordetella species. Microb. Pathog. 2:473-484.
26. Morokuma, K., A. Ginnaga, T. Nishihara, T. Shunsei, M. Furukawa, K. Aihara, and M. Sakoh. 1990. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis. Dev. Biol. Stand. 73:223-232.
27. Neimark, F. M., L. V. Lugovaya, and N. D. Belova. 1961. Bordetella parapertussis and its significance in the incidence of pertussis. Zh. Mikrobiol. Epidemiol. Immunobiol. 32:49-53.
28. Novotny, P. 1990. Pathogenesis in Bordetella species. J. Infect. Dis. 161:581-582.
29. Parton, R., and A. C. Wardlaw. 1975. Cell-envelope proteins of Bordetella pertussis. J. Med. Microbiol. 8:47-57.
30. Petersen, J. W., P. Andersen, P. H. Ibsen, C. Capiau, C. H. Wachmann, K. Hasløv, and I. Heron. 1993. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine 11:463-472.
31. Poolman, J. T., B. Kuipers, M. L. Vogel, H.-J. Hamstra, and J. Nagel. 1990. Description of a hybridoma bank towards Bordetella pertussis toxin and surface antigens. Microb. Pathog. 8:377-382.
32. Poolman, J. T., H. J. Hamstra, A. K. Barlow, B. Kuipers, H. Loggen, and J. Nagel. 1990. Outer membrane vesicles of Bordetella pertussis are protective antigens in the mouse intracerebral challenge model, p. 148-155. In C. R. Manclark (ed.). Proceedings of the Sixth International Symposium on Pertussis. DHHS publication no. (FDA) 90-1164. Department of Health and Human Services, Bethesda.
33. Redhead, K., J. Watkins, A. Barnard, and K. H. Mills. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61-3190-3198.
34. Roberts, M., I. Cropley, S. Chatfield, and G. Dougan. 1993. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA. Vaccine 11:866-872.
35. Robinson, A., A. R. Gorringe, S. G. P. Funnel, and M. Fernandez. 1989. Serospecific protection of mice against intranasal infection with Bordetella pertussis. Vaccine 7:321-324.
36. Sato, Y., and H. Aria. 1972. Leukocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization. Infect. Immun. 6:899-904.
37. Shahin, R. D., M. H. Witvliet, and C. R. Manclark. 1990. Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection. Infect. Immun. 58:4063-4068.
38. Taranger, J., B. Trollfors, T. Lagergard, and G. Zackrisson. 1994. Parapertussis infection followed by pertussis infection. Lancet 344:1703.
39. van den Berg, B. M., H. Beekhuizen, R. J. L. Willems, F. R. Mooi, and R. van Furth. 1999. Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect. Immun. 67:1056-1062.
40. Willems, R., A. Paul, H. G. J. van der Heide, A. R. ter Avest, and F. R. Mooi. 1990. Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J. 9:2803-2809.
41. Willems, R. J. L., J. Kamerbeek, C. A. W. Geuijen, J. Top, H. Gielen, W. Gaastra, and F. R. Mooi. 1998. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Vaccine 16:410-416.
42. Wright, S. D., and M. T. C. Jong. 1986. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164:1876-1888.
43. Zhang, J. M., J. L. Cowell, A. C. Steven, and C. R. Manclark. 1985. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev. Biol. Stand. 61:173-185.